Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Aveanna Healthcare Holdings Inc.

In a report released today, from UBS assigned a Hold rating to Aveanna Healthcare Holdings, with a price target of $13.00. In addition to UBS, Avea...

UBS Releases a Hold Rating on Aveanna Healthcare Holdings (AVAH)

Deutsche Bank analyst maintained a Buy rating on Aveanna Healthcare Holdings today and set a price target of $16.00. In addition to Deutsche Bank ,...

Aveanna Healthcare Holdings (AVAH) Receives a Buy from Deutsche Bank

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on PDS Biotechnology (PDSB), Cardiol Therapeutics (CRDL...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AVAH	$13.60	+0.15%	1.86M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AVAH	$13.60	+0.1%	1.86M
3
4
5
6

AVAH

Get Aveanna Healthcare Holdings Inc. Data in Excel

Get Aveanna Healthcare Holdings Inc. Data in Excel